- Business Insider Intelligence and eMarketer are now Insider Intelligence, a digitally-focused research company from Insider Inc. Learn more about what we offer.
- This story was delivered to Business Insider Intelligence Digital Health Briefing subscribers earlier this morning.
- To get this story plus others to your inbox each day, hours before they’re published on Business Insider, click here.
- Stay up-to-date with our latest coverage on the impacts of coronavirus on technology, marketing, and the digital economy here.
The Tel Aviv-based imaging startup is rolling out an AI-powered triaging tool that helps radiologists detect patients who have likely been infected with the novel coronavirus by analyzing CT scans of their lungs, according to MedCity News. The startup launched the solution after the FDA issued guidelines that permit companies with cleared triaging tools to broaden their coverage to include the novel coronavirus. For context, Aidoc has an FDA-cleared triaging tool to detect pulmonary embolism.
Business Insider Intelligence
Aidoc’s screening tool could help identify coronavirus cases that would otherwise go undiagnosed — which could help target asymptomatic carriers and halt the spread of the virus. While the American College of Radiology has advised against using CT scans to test patients for the coronavirus in the US, Aidoc’s tool could compliment and aid radiologists in their clinical decision making.
Rather than making a diagnosis, Aidoc’s solution analyzes lung CT scans and flags likely cases of the coronavirus for review by radiologists. By leveraging Aidoc’s triage tool, radiologists can identify patients who are being screened for conditions unrelated to the coronavirus as likely having contracted the virus, despite not showing symptoms. Identifying cases of the novel coronavirus that may have otherwise gone undetected will be paramount in helping to contain the highly contagious virus, considering asymptomatic carriers can unknowingly accelerate its spread.
AI-focused healthcare firms secured much-needed funding in Q1 2020 — and we expect to see investments in AI-centered healthcare startups grow as the tech increasingly proves its value. AI-centered healthcare startups raised almost $1 billion in funding in the first quarter of 2020, up from the nearly $720 million they secured in Q4 2019, per a new CB Insights report cited by STAT. This funding windfall underscores AI’s potential to drive advancements in healthcare, with use cases ranging from predictive analytics to optimizing healthcare organizations’ operations.
With the coronavirus pandemic exacerbating the stress of already overburdened healthcare workers and highlighting the necessity for providers to be able to efficiently triage the swarms of coronavirus patients flocking to hospitals across the US, AI-powered solutions could be instrumental in mitigating the pandemic’s overall impact on the US healthcare system.
So, we think AI-powered solutions will gain investment interest amid the pandemic — and heightened interest during the pandemic will generate increased investments in AI-focused healthcare startups once outbreaks subside and providers can refocus their attention on tapping into tech that can help improve their bottom lines. And we think investing in AI tools will be an attractive proposition, considering the tech can be critical in reducing clinicians’ administrative burden and augmenting providers’ clinical decision making, among other high-impact use cases.
Want to read more stories like this one? Here’s how to get access:
- Business Insider Intelligence analyzes the healthcare industry and provides in-depth analyst reports, proprietary forecasts, customizable charts, and more. >> Check if your company has BII Enterprise membership access
- Sign up for the Digital Health Briefing, Business Insider Intelligence’s expert email newsletter tailored for today’s (and tomorrow’s) decision-makers in the healthcare industry, delivered to your inbox 6x a week. >> Get Started
- Explore related topics in more depth. >> Visit Our Report Store
- Current subscribers can log in to read the briefing here.
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe